<SEC-DOCUMENT>0001493152-25-010977.txt : 20250320
<SEC-HEADER>0001493152-25-010977.hdr.sgml : 20250320
<ACCEPTANCE-DATETIME>20250320073031
ACCESSION NUMBER:		0001493152-25-010977
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250320
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250320
DATE AS OF CHANGE:		20250320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kairos Pharma, LTD.
		CENTRAL INDEX KEY:			0001962011
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				462993314
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42275
		FILM NUMBER:		25754500

	BUSINESS ADDRESS:	
		STREET 1:		2355 WESTWOOD BLVD. #139
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90064
		BUSINESS PHONE:		818-404-5541

	MAIL ADDRESS:	
		STREET 1:		2355 WESTWOOD BLVD. #139
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90064
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:KAPA="http://kairospharma.com/20250320">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_KAPA_kairospharma.com_20250320 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20250320_20250320 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001962011 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000004" name="dei:EntityCentralIndexKey">0001962011</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="kapa-20250320.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-03-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001962011</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-20</xbrli:startDate>
        <xbrli:endDate>2025-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_908_edei--DocumentType_c20250320__20250320_zz14u3wm7Hwi"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_901_edei--DocumentPeriodEndDate_c20250320__20250320_zz8QZiDbc0Y6"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">March 20, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90C_edei--EntityRegistrantName_c20250320__20250320_zYgY4tmzXZnh"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000011" name="dei:EntityRegistrantName">Kairos
Pharma, Ltd.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20250320__20250320_zxNugif9bkFa"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityFileNumber_c20250320__20250320_zDtRZoUMbhyb"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000013" name="dei:EntityFileNumber">001-42275</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20250320__20250320_zWRFi5KyCf"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000014" name="dei:EntityTaxIdentificationNumber">46-2993314</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20250320__20250320_zEehUryzc1B7"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000015" name="dei:EntityAddressAddressLine1">2355
Westwood Blvd.</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20250320__20250320_zEEsEgwPVt33"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000016" name="dei:EntityAddressAddressLine2">#139</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_901_edei--EntityAddressCityOrTown_c20250320__20250320_zJuEbdgTb8K5"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000017" name="dei:EntityAddressCityOrTown">Los
Angeles</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressStateOrProvince_c20250320__20250320_zN4xNJor5jch"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000018" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20250320__20250320_zw2pg2VViu06"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000019" name="dei:EntityAddressPostalZipCode">90064</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--CityAreaCode_c20250320__20250320_zDPp31Dxf478"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000020" name="dei:CityAreaCode">(310)</ix:nonNumeric></span>
<span id="xdx_90C_edei--LocalPhoneNumber_c20250320__20250320_zRiUZhYPAKdi"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000021" name="dei:LocalPhoneNumber">948-2356</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--WrittenCommunications_c20250320__20250320_zzY3kpsy7Il"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SolicitingMaterial_c20250320__20250320_zX6y9jFB8Ja5"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20250320__20250320_zuRHXNJ28T8j"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20250320__20250320_zlH1Llci4WB5"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol (s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20250320__20250320_z6Drr5ov9sqh"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value
    $0.001, per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20250320__20250320_zN0JidJt1Ttg"><ix:nonNumeric contextRef="AsOf2025-03-20" id="Fact000027" name="dei:TradingSymbol">KAPA</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SecurityExchangeName_c20250320__20250320_zKpMtYfslztg"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">NYSE American</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20250320__20250320_zDG7dA86o8vj"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_908_edei--EntityExTransitionPeriod_c20250320__20250320_zP7GbKw5FNyg"><ix:nonNumeric contextRef="AsOf2025-03-20" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 20, 2025, Kairos Pharma, Ltd., a Delaware corporation (the &#8220;Company&#8221;), issued a press release announcing a peer-reviewed
publication highlighting a potentially significant breakthrough in addressing drug resistance to EGFR-targeted therapies for non-small
cell lung cancer (&#8220;NSCLC&#8221;) patients. Recent findings published in Drug Resistance Updates highlight the critical role of
CD105 (&#8220;endoglin&#8221;) in mediating resistance to osimertinib, a frontline treatment for EGFR-mutant NSCLC. The study, entitled
&#8220;CD105 blockade restores osimertinib sensitivity in drug-resistant EGFR-mutant non-small cell lung cancer&#8221; demonstrated that
CD105 expression is upregulated as a mechanism of therapy resistance, correlating with poor prognosis in patients.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated March 20, 2025</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive
    Data File (embedded within Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">SIGNATURE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 20, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>KAIROS PHARMA, LTD.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ John
    S. Yu</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John S. Yu</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZi6YpXdilRUWsIkXEbbSjBNtMmcSqR/KWxhZxGBiG/9//QozEkhamRobjrCxgj01ba49Q4gUZ7RmDI1+tMwi3xKtxnrX1/fsDcwoMBiYdq/QUhN7aGYdVBjKZxNOJSkGqTCaw24joq+dkL6ZC642uQdsKdkwtG/SaX0PCXj/JUvPqqw7IzpDNIB7LQX6DkrGCLXX6QXxzUBS5iEb9RGLJdG+Da/70aL8kzGtsQp0b6P9GHwiASo8= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Kairos
Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small
Cell Lung Cancer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LOS
ANGELES &ndash; March 20, 2025</B> &ndash; Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces
a peer-reviewed publication highlighting a potentially significant breakthrough in addressing drug resistance to EGFR-targeted therapies
for non-small cell lung cancer (NSCLC) patients. Recent findings published in <I>Drug Resistance Updates</I> highlight the critical role
of CD105 (endoglin) in mediating resistance to osimertinib, a frontline treatment for EGFR-mutant NSCLC. The study, entitled &ldquo;CD105
blockade restores osimertinib sensitivity in drug-resistant EGFR-mutant non-small cell lung cancer&rdquo; demonstrated that CD105 expression
is upregulated as a mechanism of therapy resistance, correlating with poor prognosis in patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
believe our latest findings represent a paradigm shift in overcoming resistance to EGFR-targeted therapies in NSCLC,&rdquo; said Neil
Bhowmick, Ph.D., Kairos Pharm Chief Scientific Officer. &ldquo;Revealing this mechanism-of-action underscores our commitment to advancing
precision oncology and bringing innovative therapies to patients in need.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
preclinical models, targeting CD105 with ENV105 (carotuximab), a CD105-neutralizing antibody successfully restored treatment sensitivity
to EGFR-targeted therapies. Notably, combining osimertinib with ENV105 reinstated susceptibility to EGFR inhibition through metabolic
reprogramming and enhanced chromatin accessibility. These findings confirm the efficacy of this novel combination therapy strategy in
overcoming drug resistance in this model of non-small cell lung cancer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
John Yu, CEO stated, &ldquo;These findings in lung cancer corroborate data in prostate cancer, breast cancer and colon cancer, that point
to CD105 being a central mechanism of cancer drug resistance.&rdquo; We believe ENV105 can reverse this resistance in cancer models,
and our clinical trials are designed to definitively demonstrate its potential impact.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global NSCLC treatment market is projected to reach $45 billion by 2030, driven by advancements in targeted therapies. However, drug
resistance remains a major challenge. The ability of ENV105 to enhance EGFR-targeted therapy effectiveness positions it as a high-value
asset in next-generation oncology treatment. Kairos Pharma is currently evaluating this transformative cancer therapy in ongoing clinical
trials for EGFR-driven lung cancer patients. The study can be accessed <U>here</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Kairos Pharma Ltd.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
in Los Angeles, California, Kairos Pharma Ltd. (<U>NYSE American: KAPA</U>) is at the forefront of oncology therapeutics, utilizing structural
biology to overcome drug resistance and immune suppression in cancer. Our lead candidate, ENV105, is an antibody that targets CD105 &ndash;
a protein identified as a key driver of resistance to various cancer treatments. Elevation of CD105 in response to standard therapy results
in resistance and disease relapse. ENV105 aims to reverse drug resistance by targeting CD105 and restore the effectiveness of standard
therapies across multiple cancer types. Currently, ENV105 is in a Phase 2 clinical trial for castrate-resistant prostate cancer and a
Phase 1 trial for lung cancer aimed at addressing significant unmet medical needs. For more information, visit <U>kairospharma.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAUTIONARY
STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking statements&rdquo; as defined in the Private Securities Litigation Reform Act of 1995. You
can identify forward-looking statements as those that are not historical in nature, particularly those that use terminology such as &ldquo;may,&rdquo;
&ldquo;should,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;contemplates,&rdquo; &ldquo;estimates,&rdquo; &ldquo;believes,&rdquo;
&ldquo;plans,&rdquo; &ldquo;projected,&rdquo; &ldquo;predicts,&rdquo; &ldquo;potential&rdquo; or &ldquo;hopes&rdquo; or the negative
of these or similar terms. The reader is cautioned not to rely on these forward-looking statements. If underlying assumptions prove inaccurate,
or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of
Kairos Pharma. We base these forward-looking statements on our expectations and projections about future events, which we derive from
the information currently available to us. Such forward-looking statements relate to future events or our future performance. In evaluating
these forward-looking statements, you should consider various factors, including: our expectations regarding the success and/or completion
of our Phase 1 and Phase 2 clinical trials; our success in completing newly initiated clinical trials, commence new trials, and obtain
regulatory approval following the conclusion of such trials; challenges and uncertainties inherent in product research and development;
and the uncertainty regarding future commercial success. These and other factors may cause our actual results to differ materially from
any forward-looking statement. Forward-looking statements are only predictions. The forward-looking statements discussed in this press
release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ
materially and are subject to risks, uncertainties and assumptions about us, including those described in Kairos Pharma&rsquo;s prospectus
and our other filings made with the SEC. We are not obligated to publicly update or revise any forward-looking statement, and Kairos
Pharma is not required to update any forward-looking statement as a result of new information or future events or developments, except
as required by U.S. federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORE
IR</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louie
Toma</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors@kairospharma.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !9 ,@# 2(  A$! Q$!_\0
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M:ZBTE=T_KN#Y_=2_?PY7)JHJ4[=#]#_*H+ETC0.S)'M)(DD.$CPI+.6/RKA
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MEUW5(KF73](35=7GM[4W][%:7+P0>9O,<$TN"L35[*QP/^!*/S8 _I7\P?\
MP=H*K?\ !,?PJ'2:0']JCX2*5@0R7!$FB>.(V6UC#Q&6\=7,=I")8M\SJ?,4
M)SZF0932SW.LMR>M6J8:EF.*CAIUZ-O:4>:G6G&I&[6D9TH.>M_9^TLG+E3Y
ML96GAL+6KTX.I.E!24%:\O?IQ>[2TC*3W^SWL?T5> OBCX*^*_@SPU\2OA7X
MG\.?$3X>>-=,CUCP?XT\):M'K/ASQ-I<\C6]OJ.CZKIT=W;7UA+<JZ27=MYR
MP11^9$+UF\N/Q#PA^W)^R1XU^*R?L_\ A;]I/X(>*/CG#J.MZ)J'PL\-^/\
M0M6\;6NL^$_^1ILIO#.F7^I:A9R:$R2Q:LEU)]GTNZ'V.6_N7B=V_AT\9_\
M!:O6O@)_P23_ &&/^"?7[%WB/SOVGO'GP*TOPI\8_BIX=UF'2C\$+/Q;XEO=
M)T/P-X2UJYFL;"S^*7C@:L]U;>+[[5;"W^$OAI8=8OP-8UHR>&OZ6_\ @BC_
M ,$;?A__ ,$N/@[<>(_&&G^&_%7[6?Q,TW2)OBSX[L81?VG@K3XQ+<VGP?\
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M\/TZ?$=>OB<UK4,RKU:F0U<S=>EBJE7^QJS6!K0E.$E#VL:G+S*JH.K&#?\
MEMXLYA]+KP4X"Q' ^2\:X_/?"7 8..68'B/(,!@HYQEN4X*G.K2RC,,^A2EF
M67X=T)>SQ6*INE"<81PL*L%5E%]5I-[XCFOX[7PG8:KXF\?^*@_ASPAHUBUS
M>Z]J_BKQ>&TZV^SRWA-Q=:O#]OO;VUDD:VM;>2W:ZN[ZRMK>XNH/Z(OV*/\
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MS=I[_P#!3:W\-7'[.\GQ)\-1Z>OBEO'D=@/B*=.UP>'&MI?AS/#XBCOO[/\
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MO)WU2^^('PLU"S7P=X[L[^2XU:^TN/PUXJU&74;Z\UEM&^IO@A_P6I_X(:_
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MUGP)IMWK/AO0+R7XC:C>WR0Z%I_Q%O;R*TL88K>Z.K"6^DN)K'238^Y_M_\
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ML?"R1VNI>)6T72+-UTOXFV6@7-I9ZOH>N?#]Y;^\&FR?\)7X8\#3W,>EW_\
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M:TS5]=OIKGQE!X4T(BRB=Y%N=-&F7L5E);W.F31A-GX!?\$P/$%[X'\(?\'
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MOM#6>FV?B>31M#_:7^'T5GYEI!=7?P9D\5^"?&5WIS^<'CM]+G!F!M_+Z_\
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MC"491<E=V=E)/[5M%R8S+\-C+QKP4DTT]%Z_=[JT^9^-_P#P39_X(M?L^?\
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+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>kapa-20250320.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamLabP9z5Z8SekhvWB1bWmq/ygr8KnMtS1K0M7G8a4P -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:KAPA="http://kairospharma.com/20250320" elementFormDefault="qualified" targetNamespace="http://kairospharma.com/20250320">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://kairospharma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="kapa-20250320_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="kapa-20250320_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>kapa-20250320_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>kapa-20250320_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://kairospharma.com/role/Cover" xlink:href="kapa-20250320.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://kairospharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 20,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Kairos
Pharma, Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001962011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-2993314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2355
Westwood Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">#139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los
Angeles<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">948-2356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value
    $0.001, per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KAPA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,\[=%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( ,\[=%HR>OJ [@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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M,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
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MYHOA/UY_ 5!+ 0(4 Q0    ( ,\[=%I&QTU(E0   ,T    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ SSMT6C)Z^H#N
M    *P(  !$              ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ SSMT6IE<G",0!@  G"<  !,              ( !X $  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #/.W1:;]_N&Y,$  #0$0
M&               @($A"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ SSMT6I^@&_"Q @  X@P   T              ( !Z@P  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " #/.W1:EXJ[',     3 @  "P
M        @ '&#P  7W)E;',O+G)E;'-02P$"% ,4    " #/.W1:JL0B%C,!
M   B @  #P              @ &O$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ SSMT6B0>FZ*M    ^ $  !H              ( !#Q(  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ SSMT6F60>9(9 0
MSP,  !,              ( !]!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      D "0 ^ @  /A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kairospharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>kapa-20250320.xsd</File>
    <File>kapa-20250320_lab.xml</File>
    <File>kapa-20250320_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "KAPA",
   "nsuri": "http://kairospharma.com/20250320",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "kapa-20250320.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "kapa-20250320_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kapa-20250320_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://kairospharma.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://kairospharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-25-010977-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-010977-xbrl.zip
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M=U^1AE6:)_>] TSK]+X7H5'C[DB%=;([H]?E_MT7!(MWQ5TW8:KG@,OP:F$
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M]*1\]_-0.%^&6;5T43G\/.*UCE7>\SB242U]@C_[8F!4_P=02P,$%     @
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ME0P  -,R   *              "  0    !E>#DY+3$N:'1M4$L! A0#%
M  @ SSMT6H(U7%0[$P  798   L              ( !O0P  &9O<FTX+6LN
M:'1M4$L! A0#%     @ SSMT6L/[,B8M P  [PL  !$              ( !
M(2   &MA<&$M,C R-3 S,C N>'-D4$L! A0#%     @ SSMT6B'+R6;^"@
M@(8  !4              ( !?2,  &MA<&$M,C R-3 S,C!?;&%B+GAM;%!+
M 0(4 Q0    ( ,\[=%JV\='47 <  -U7   5              "  :XN  !K
J87!A+3(P,C4P,S(P7W!R92YX;6Q02P4&      4 !0 V 0  /38

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="kapa-20250320.xsd" xlink:type="simple"/>
    <context id="AsOf2025-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001962011</identifier>
        </entity>
        <period>
            <startDate>2025-03-20</startDate>
            <endDate>2025-03-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-03-20" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-03-20" id="Fact000004">0001962011</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-03-20" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-03-20" id="Fact000010">2025-03-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-03-20" id="Fact000011">Kairos Pharma, Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-03-20" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-03-20" id="Fact000013">001-42275</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-03-20" id="Fact000014">46-2993314</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-03-20" id="Fact000015">2355 Westwood Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-03-20" id="Fact000016">#139</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-03-20" id="Fact000017">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-03-20" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-03-20" id="Fact000019">90064</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-03-20" id="Fact000020">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-03-20" id="Fact000021">948-2356</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-03-20" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-03-20" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-03-20" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-03-20" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-03-20" id="Fact000026">Common Stock, par value     $0.001, per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-03-20" id="Fact000027">KAPA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-03-20" id="Fact000028">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-03-20" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-03-20" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
